Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different bowel cleansing regimens in chronic constipation before colonoscopy
ChiCTR2300077136Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of macrogol 4000, macrogol and simethicone in chronic constipation (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Bowel cleanliness. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
macrogol 4000macrogolsimethicone
03
Conditions
chronic constipation
Beyond the preview
Go deeper on ChiCTR2300077136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077136.